Zur Merkliste hinzufügen
Zurück

 

19664-01 - Seminar: Evaluation of compound properties 1 KP

Semester Frühjahrsemester 2020
Angebotsmuster Jedes Frühjahrsem.
Dozierende Matthias Hamburger (matthias.hamburger@unibas.ch, BeurteilerIn)
Inhalt The seminar will address the evaluation of physico-chemical, pharmacological/toxicological and biopharmaceutical properties of drugs, with a series of case studies. Case studies are on industrial discovery and development projects where the novel drug substance is in clinical development. Students will work in teams of 2 on a specific case. The individual projects, and specific questions to be addressed by the teams will be briefly presented by the lecturer at the start of the seminar. Students then select their individual projects. As a starting point groups will receive selected literature for their case study, and a catalogue of key questions to be addressed. The teams will address these questions, and discuss the specific case within the wider context, eg. possible industrial competitor projects addressing the same drug target.
Lernziele Participants know and understand the parameters which are important for the pharmaceutical and pharmacological/toxicological profiling of a compound. They are able to evaluate the suitability of a molecule as drug substance.They are able to evaluate the outcomes of a specific drug development program against the background of current knowledge. Students are able to summarize their findings in a concise written and oral form.
Literatur Key literature on each case study, and a catalogue of questions to be addressed, will be prepared and handed out by the lecturer. As general reference, the following book can be consulted: Molecular Drug Properties. Measurement and Prediction. R. Mannhold, H. Kubinyi, G. Folkers, Wiley-VCH 2007
Bemerkungen The seminar will be in English. The written report and oral presentation will be in English.
Film and sound recordings during the course are strictly forbidden (recorders may be confiscated).

 

Teilnahmebedingungen Admission to the MSc in Drug Sciences
Number of participants limited to 12.
Attention: Students who want to attend have to send an email to manuela.rogalski@unibas.ch until 10 February 2020 at latest.
You will be immediately informed whether you can attend or whether seminar is full, based on a First-come-First-Served basis.
Only after receiving the email confirmation by Manuela Rogalski you can register for the seminar in MONA!
Unterrichtssprache Englisch
Einsatz digitaler Medien kein spezifischer Einsatz

 

Intervall wöchentlich
Datum 19.02.2020 – 08.04.2020
Zeit Mittwoch, 10.15-12.00 Pharmazentrum, Seminarraum 5026
Datum Zeit Raum
Mittwoch 19.02.2020 10.15-12.00 Uhr Pharmazentrum, Seminarraum 5026
Mittwoch 26.02.2020 10.15-12.00 Uhr Pharmazentrum, Seminarraum 5026
Mittwoch 04.03.2020 10.15-12.00 Uhr Fasnachtsferien
Mittwoch 11.03.2020 10.15-12.00 Uhr Pharmazentrum, Seminarraum 5026
Mittwoch 18.03.2020 10.15-12.00 Uhr Pharmazentrum, Seminarraum 5026
Mittwoch 25.03.2020 10.15-12.00 Uhr Pharmazentrum, Seminarraum 5026
Mittwoch 01.04.2020 10.15-12.00 Uhr Pharmazentrum, Seminarraum 5026
Mittwoch 08.04.2020 10.15-12.00 Uhr Pharmazentrum, Seminarraum 5026
Module Wahlbereich Master Drug Sciences: Empfehlungen (Masterstudium: Drug Sciences)
Wahlbereich Master Pharmazie: Empfehlungen (Masterstudium: Pharmazie)
Leistungsüberprüfung Lehrveranst.-begleitend
Hinweise zur Leistungsüberprüfung An oral presentation and a written report of the case study. pass/fail
An-/Abmeldung zur Leistungsüberprüfung An-/Abmelden: Belegen resp. Stornieren der Belegung via MOnA
Wiederholungsprüfung keine Wiederholungsprüfung
Skala Pass / Fail
Wiederholtes Belegen beliebig wiederholbar
Zuständige Fakultät Philosophisch-Naturwissenschaftliche Fakultät, studiendekanat-philnat@unibas.ch
Anbietende Organisationseinheit Departement Pharmazeutische Wissenschaften

Zurück